Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients (original) (raw)

Nature volume 356, pages 713–715 (1992)Cite this article

Abstract

DEFECTS in the NF1 gene have been implicated in the inherited disorder neurofibromatosis type 1, which is characterized by several developmental abnormalities including an increased frequency of benign and malignant tumours of neural crest origin (neuro-fibromas and neurofibrosarcomas respectively)1. The NF1 gene encodes a ubiquitous protein homologous to p!20GAP, the GTPase-activating protein (GAP) for the products of the ras proto-oncogenes2–6. When expressed in non-mammalian systems, the region of the NF1 gene homologous to p!20GAP produces a protein with GAP-like activity7–9. Here we present evidence that the ras proteins in malignant tumour cell lines from patients with type 1 neurofibromatosis are in a constitutively activated state, as judged by the guanine nucleotide bound to them, and are necessary for cellular proliferation. These cells contain P21_ras_and p120GAP that are both functionally wild type, but barely any functional NF1 protein. Our results show that the NF1 protein is normally essential for correct negative regulation of ras proteins in the cell, even in the presence of normal p120GAP, and they support the hypothesis that NF1 is a tumour-suppressor gene whose product acts upstream of ras.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Riccardi, V. & Eichner, J. Neurofibromatosis: Phenotype, Natural History and Pathogenesis (Johns Hopkins Univ. Press, Baltimore, 1986).
    Google Scholar
  2. Viskochil, D. et al. Cell 62, 187–192 (1990).
    Article CAS Google Scholar
  3. Cawthorn, R. M. et al. Cell 62, 193–201 (1990).
    Article Google Scholar
  4. Wallace, M. R. et al. Science 249, 181–186 (1990).
    Article ADS CAS Google Scholar
  5. Xu, G. et al. Cell 62, 599–608 (1990).
    Article CAS Google Scholar
  6. Buchberg, A. M., Cleveland, L. S., Jenkins, N. A. & Copeland, N. G. Nature 347, 291–294 (1990).
    Article ADS CAS Google Scholar
  7. Xu, G. et al. Cell 63, 835–841 (1990).
    Article CAS Google Scholar
  8. Martin, G. A. et al. Cell 63, 843–849 (1990).
    Article CAS Google Scholar
  9. Ballester, R. et al. Cell 63, 851–859 (1990).
    Article CAS Google Scholar
  10. Downward, J. Curr. Opin. dev. Genet. 2, 13–18 (1992).
    Article CAS Google Scholar
  11. Downward, J., Graves, J. D., Warne, P. H., Rayter, S. & Cantrell, D. A. Nature 346, 719–723 (1990).
    Article ADS CAS Google Scholar
  12. Hattori, S. et al. Biochem. biophys. Res. Commun. 177, 83–89 (1991).
    Article CAS Google Scholar
  13. Gutmann, D. H., Wood, D. L. & Collins, F. S. Proc. natn. Acad. Sci. U.S.A. 88, 9658–9662 (1991).
    Article ADS CAS Google Scholar
  14. Fletcher, J. A. et al. New Engl. J. Med. 324, 436–443 (1991).
    Article CAS Google Scholar
  15. Glover, T. W. et al. Genes, Chromosomes Cancer 3, 62–70 (1991).
    Article CAS Google Scholar
  16. Nigro, J. M. et al. Nature 342, 705–708 (1989).
    Article ADS CAS Google Scholar
  17. Ridley, A. J., Paterson, H. F., Noble, M. & Land, H. EMBO J. 7, 1635–1645 (1988).
    Article CAS Google Scholar
  18. Menon, A. G. et al. Proc. natn. Acad. Sci. U.S.A. 87, 5435–5439 (1990).
    Article ADS CAS Google Scholar
  19. Downward, J., de Gunzburg, J., Riehl, R. & Weinberg, R. A. Proc. natn. Acad. Sci. U.S.A. 85, 5774–5778 (1988).
    Article ADS CAS Google Scholar
  20. Cantrell, D. A., Collins, M. K. & Crumpton, M. J. Immunology 65, 343–349 (1988).
    CAS PubMed PubMed Central Google Scholar
  21. Harlow, E. & Lane, D. Antibodies: a Laboratory Manual (Cold Spring Harbor Laboratory, New York, 1988).
    Google Scholar
  22. Smith, M. R., DeGudicubus, S. J. & Stacey, D. W. Nature 320, 540–543 (1986).
    Article ADS CAS Google Scholar

Download references

Author information

Author notes

  1. Julian Downward: To whom correspondence should be addressed

Authors and Affiliations

  1. Signal Transduction Laboratory, Imperial Cancer Research Fund, Lincoln's Inn Fields, London, WC2A 3PX, UK
    Tanya N. Basu & Julian Downward
  2. Howard Hughes Medical Institute and Departments of Internal Medicine and Human Genetics, University of Michigan Medical School, Ann Arbor, Michigan, 48109, USA
    David H. Gutmann & Francis S. Collins
  3. Department of Pathology, Brigham and Women's Hospital, 75 Francis Street, Boston, Massachusetts, 02115, USA
    Jonathan A. Fletcher
  4. Departments of Pediatrics and Human Genetics, University of Michigan Medical School, Ann Arbor, Michigan, 48109, USA
    Thomas W. Glover

Authors

  1. Tanya N. Basu
    You can also search for this author inPubMed Google Scholar
  2. David H. Gutmann
    You can also search for this author inPubMed Google Scholar
  3. Jonathan A. Fletcher
    You can also search for this author inPubMed Google Scholar
  4. Thomas W. Glover
    You can also search for this author inPubMed Google Scholar
  5. Francis S. Collins
    You can also search for this author inPubMed Google Scholar
  6. Julian Downward
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Basu, T., Gutmann, D., Fletcher, J. et al. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients.Nature 356, 713–715 (1992). https://doi.org/10.1038/356713a0

Download citation